Post-Trade Analysis: Rigel Pharmaceuticals (RIGL) Climbs 1.15, Closing at 18.47

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

After finishing at $18.26 in the prior trading day, Rigel Pharmaceuticals (NASDAQ: RIGL) closed at $18.47, up 1.15%. In other words, the price has increased by $1.15 from its previous closing price. On the day, 0.71 million shares were traded.

Ratios:

Our goal is to gain a better understanding of RIGL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 10.50. For the most recent quarter (mrq), Quick Ratio is recorded 1.98 and its Current Ratio is at 2.13. In the meantime, Its Debt-to-Equity ratio is 18.23 whereas as Long-Term Debt/Eq ratio is at 15.93.

Piper Sandler Downgraded its Overweight to Neutral on June 08, 2022, whereas the target price for the stock was revised from $7 to $1.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 04 ’25 when Schorno Dean L sold 2,036 shares for $20.92 per share. The transaction valued at 42,595 led to the insider holds 58,969 shares of the business.

Schorno Dean L sold 1,734 shares of RIGL for $38,020 on Feb 05 ’25. The EVP & Chief Financial Officer now owns 57,235 shares after completing the transaction at $21.93 per share. On Feb 04 ’25, another insider, Santos David A, who serves as the EVP, Chief Commercial Officer of the company, sold 2,125 shares for $20.92 each. As a result, the insider received 44,457 and left with 53,500 shares of the company.

Valuation Measures:

As of this moment, Rigel’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.01, and their Forward P/E ratio for the next fiscal year is 9.31. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.84 while its Price-to-Book (P/B) ratio in mrq is 99.48.

Stock Price History:

Over the past 52 weeks, RIGL has reached a high of $29.82, while it has fallen to a 52-week low of $7.48. The 50-Day Moving Average of the stock is -2.97%, while the 200-Day Moving Average is calculated to be 4.52%.

Shares Statistics:

A total of 17.71M shares are outstanding, with a floating share count of 17.38M. Insiders hold about 2.71% of the company’s shares, while institutions hold 69.37% stake in the company.

Most Popular